Impact of acute renal failure on the relationship between N-Terminal pro-B-type natriuretic peptide and hemodynamic parameters

Blood Purification

Volumn 31, Issue 1-3, 2011, Pages 47-54

  Balik, Martin ^a   Jabor, Antonin ^b   Otahal, Michal ^a   Waldauf, Petr ^c   Pavlisova, Marie ^d  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

^d Nemocnice Kladno   (Czech Republic)

Author keywords

Acute renal failure; Continuous hemodiafiltration; Echocardiography; Intensive care; Left ventricular function; N terminal pro B type natriuretic peptide

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ACUTE KIDNEY FAILURE; ADULT; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTINUOUS HEMODIAFILTRATION; CONTROLLED STUDY; DIURESIS; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEMODYNAMIC PARAMETERS; HUMAN; LUNG ARTERY PRESSURE; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLE; TRICUSPID VALVE; VENTILATED PATIENT;

ACUTE KIDNEY INJURY; AGED; COHORT STUDIES; FEMALE; HEART VENTRICLES; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; VENTRICULAR DYSFUNCTION, LEFT;

EID: 78650041772     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000322259     Document Type: Conference Paper

References (30)

1. Levitt JE, Vinayak AG, Gehlbach BK, Pohlman A, Van Cleve W, Hall JB, Kress JP: Diagnostic utility of B-type natriuretic peptide in critically ill patients with pulmonary edema: a prospective cohort study. Crit Care 2008; 12:R3.
2. Betti I, Castelli G, Barchielli A, Cinzia B, Boscherini V, De Luca L, Messeri G, Gheorghiade M, Maisel A, Zuppiroli A: The role of N-terminal PRO-brain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure. The PROBE-HF study. J Card Fail 2009; 15: 377-384.
3. O'Donoghue M, Chen A, Baggish AL, Anwaruddin S, Krauser DG, Tung R, Januzzi JL: The effects of ejection fraction on N-terminal ProBNP and BNP levels in patients with acute CHF: analysis from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. J Card Fail 2005; 11:S9-S14.
4. Levin ER, Gardner DG, Samson WK: Natriuretic peptides. N Engl J Med 1998; 339: 321-328.
5. Shimizu H, Masuta K, Asada H, Sugita K, Sairenji T: Characterization of molecular forms of probrain natriuretic peptide in human plasma. Clin Chim Acta 2003; 334: 233-239.
6. McLean A, Huang S, Hyams S, Poh G, Nalos M, Pandit R, Balik M, Tang B, Seppelt I: Prognostic values of B-type natriuretic peptide in severe sepsis and septic shock. Crit Care Med 2007; 35: 1019-1026.
7. Jefic D, Lee JW, Jefic D, Savoy-Moore RT, Rosman HS: Utility of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in evaluation of respiratory failure in critically ill patients. Chest 2005; 128: 288-295.
8. Meyer B, Huelsmann M, Wexberg P, Karth GD, Berger R, Moertl D, Szekeres T, Pacher R, Heinz G: N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients. Crit Care Med 2007; 35: 2268-2273.
9. Charpentier J, Luyt CE, Fulla Y, Vinsonneau C, Cariou A, Grabar S, Dhainaut JF, Mira JP, Chiche JD: Brain natriuretic peptide: a marker of myocardial dysfunction and prognosis during severe sepsis. Crit Care Med 2004; 32: 660-665.
10. Rana R, Vlahakis VE, Daniels CE, Jaffe AS, Klee GG, Hubmayr RD, Gajic O: B-type natriuretic peptide in the assessment of acute lung injury and cardiogenic pulmonary edema. Crit Care Med 2006; 34: 1941-1946.
11. Mekontso-Dessap A, de Prost N, Girou E, Braconnier F, Lemaire F, Brun-Buisson C, Brochard L: B-type natriuretic peptide and weaning from mechanical ventilation. Intensive Care Med 2006; 32: 1529-1536. (Pubitemid 44484342)
12. Phua J, Lim TK, Lee KH: B-type natriuretic peptide: Issues for the intensivist and pulmonologist. Crit Care Med 2005; 33: 2094-2103.
13. Logeart D, Saudubray C, Beyne P, Thabut G, Ennezat PV, Chavelas C, Zanker C, Bouvier E, Solal AC: Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea. J Am Coll Cardiol 2002; 40: 1794-1800.
14. Pirracchio R, Deye N, Lukaszewicz AC, Mebazaa A, Cholley B, Mateo J, Megarbane B, Launay LM, Peynet J, Baud F, Payen D: Impaired plasma B-type natriuretic peptide clearance in human septic shock. Crit Care Med 2008; 36: 2542-2546.
15. Smith MW, Espiner EA, Yandle YA, Charles CJ, Richards AM: Delayed metabolism of human brain natriuretic peptide reflects resistance to neutral endopeptidase. J Endocrinol 2000; 167: 239-246.
16. Krauser DG, Lloyd-Jones DM, Chae CU, Cameron R, Anwaruddin S, Baggish AL, Chen A, Tung R, Januzzi JL Jr: Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy. Am Heart J 2005; 149: 744-750.
17. Das SR, Abdullah SM, Leonard D, Drazner MH, Khera A, McGuire DK, de Lemos JA: Association between renal function and circulating levels of natriuretic peptides (from the Dallas Heart Study). Am J Cardiol 2008; 102: 1394-1398.
18. Anwaruddin S, Lloyd-Jones DM, Baggish A, Chen A, Krauser D, Tung R, Chae C, Januzzi JL: Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study. J Am Coll Cardiol 2006; 47: 91-97.
19. Jarai R, Fellner B, Haoula D, Jordanova N, Heinz G, Karth GD, Huber K, Geppert A: Early assessment of outcome in cardiogenic shock: relevance of plasma N-terminal pro- B-type natriuretic peptide and interleukin-6 levels. Crit Care Med 2009; 37: 1837-1844.
20. Balik M, Jabor A, Kolar M, Pavlisova M, Brestan D, Hendl J, Rychlik I, Pachl J: Relationship between natriuretic peptides and residual diuresis during continuous hemodiafiltration. Blood Purif 2003; 21: 401-408.
21. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, and the ADQI Workgroup: Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Critical Care 2004; 8:R204-R212
22. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G: SCCM/ESICM/ACCP/ ATS/SIS 2001. SCCM/ESICM/ACCP/ATS/ SIS International Sepsis Definitions Conference. Crit Care Med 2003; 31: 1250-1256. (Pubitemid 36444440)
23. Otto MC: Echocardiographic evaluation of left and right ventricular systolic function; in Otto MC (ed): Textbook of Clinical Echocardiography. Philadelphia, Saunders, 2000, pp 100-131.
24. Nishimura RA, Tajik AJ: Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's rosseta stone. J Am Coll Cardiol 1997; 30: 8-18.
25. Lonnemann G, Linnenweber S, Burg M, Koch KM: Transfer of endogenous pyrogens across artificial membranes? Kidney Int 1998; 53: 43-46.
26. Bragg-Gresham JL, Fissell RB, Mason NA, Bailie GR, Gillespie BW, Wizemann V, Cruz JM, Akiba T, Kurokawa K, Ramirez S, Young EW: Diuretic use, residual renal function, and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Pattern Study (DOPPS). Am J Kidney Dis 2007; 49: 426-431.
27. Guerin C, Girard R, Selli JM, Ayzac L: Intermittent versus continuous renal replacement therapy for acute renal failure in intensive care units: results from a multicenter prospective epidemiological survey. Intensive Care Med 2002; 28: 1411-1418.
28. Uchino S, Doig GS, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Nacedo E, Gibney N, Tolwani A, Ronco C, Kellum JA: Beginning and ending supportive therapy for the kidney (BEST kidney) investigators. Crit Care Med 2004; 32: 1669-1677.
29. Chen AA, Wood MJ, Krauser DG, Baggish AL, Tung R, Anwaruddin S, Picard MH, Januzzi JL Jr: NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy. Eur Heart J 2006; 27: 839-845.
30. Kotanidou A, Karsaliakos P, Tzanela M, Mavrou I, Kopterides P, Papadomichelakis E, Theodorakopoulou M, Botoula E, Tsangaris I, Lignos M, Ikonomidis I, Ilias I, Armaganidis A, Orfanos SE, Dimopoulou I: Prognostic importance of increased plasma amino-terminal pro-brain natriuretic peptide levels in a large noncardiac, general intensive care unit population. Shock 2009; 31: 342-347.